CLINICAL NEUROPHARMACOLOGY, vol.33, no.3, pp.155-157, 2010 (SCI-Expanded)
Purpose: This study was carried out to determine the effects of valproate (VPA), carbamazepine, and levetiracetam (LEV) on antioxidant and oxidant enzyme activities and the clinical importance of these effects.